It doesn't work that way. I believe dror misspoke and/or is wrong. I followed this process closely with CLDX and other companies. I believe the company knows when the period of twelve months has occurred in half the patients--lets call this date D-Day. When D-Day occurs-the data review board will meet--but not right away--there is a period of one month--to even six weeks until this actual date. The data review board will then issue a specific go/no go recommendation. They will recommend a no-go rec if the company has not met futility, or a go if futility is met. I highly doubt this will leak out in even the slightest manner... it could happen, but highly doubtful. So you can discount both a price rise/or price decline in the days before such a decision.
So, you can discount a price decline or rise has having any meaning, at least in terms of the outcome of the interim analysis. A partnership for NASH, on the other hand, might start to leak out in the days before a final inking of the deal, but I doubt it. Will have to simply wait and suffer until the interim comes out =)
News 
Market Data 
Discover 
